Literature DB >> 25432782

An independent validation of the Global Anti-Phospholipid Syndrome Score in a Japanese cohort of patients with autoimmune diseases.

K Oku1, O Amengual2, T Bohgaki2, T Horita2, S Yasuda2, T Atsumi2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25432782     DOI： 10.1177/0961203314561284

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  11 in total

Review 1.  Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

2.  The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.

Authors:  Massimo Radin; Savino Sciascia; Doruk Erkan; Vittorio Pengo; Maria G Tektonidou; Amaia Ugarte; Pierluigi Meroni; Lanlan Ji; H Michael Belmont; Hannah Cohen; Guilherme Ramires de Jesús; D Ware Branch; Paul R Fortin; Laura Andreoli; Michelle Petri; Esther Rodriguez; Ignasi Rodriguez-Pinto; Jason S Knight; Tatsuya Atsumi; Rohan Willis; Emilio Gonzalez; Rosario Lopez-Pedrera; Ana Paula Rossi Gandara; Margarete Borges Gualhardo Vendramini; Alessandra Banzato; Ecem Sevim; Medha Barbhaiya; Maria Efthymiou; Ian Mackie; Maria Laura Bertolaccini; Danieli Andrade
Journal:  Semin Arthritis Rheum       Date:  2019-05-02       Impact factor: 5.532

Review 3.  Diagnosis and management of the antiphospholipid syndrome.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Blood Rev       Date:  2017-07-30       Impact factor: 8.250

4.  Improvements in diagnosis and risk assessment of primary and secondary antiphospholipid syndrome.

Authors:  Michelle Petri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

5.  Validation of the adjusted global antiphospholipid syndrome score in a single centre cohort of APS patients from Turkey.

Authors:  Ömer Uludağ; Murat Bektaş; Erhan Çene; Murat Sezer; Yasemin Şahinkaya; Ahmet Gül; Murat Inanç; Lale Öcal; Bahar Artim-Esen
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

Review 6.  How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores.

Authors:  Kenji Oku; Olga Amengual; Shinsuke Yasuda; Tatsuya Atsumi
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

Review 7.  Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.

Authors:  Savino Sciascia; Mary-Carmen Amigo; Dario Roccatello; Munther Khamashta
Journal:  Nat Rev Rheumatol       Date:  2017-08-03       Impact factor: 20.543

Review 8.  Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay.

Authors:  Savino Sciascia; Simone Baldovino; Karen Schreiber; Laura Solfietti; Massimo Radin; Maria J Cuadrado; Elisa Menegatti; Doruk Erkan; Dario Roccatello
Journal:  Clin Mol Allergy       Date:  2016-07-15

Review 9.  Recent advances in understanding antiphospholipid syndrome.

Authors:  Maria Laura Bertolaccini; Giovanni Sanna
Journal:  F1000Res       Date:  2016-12-22

Review 10.  Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review.

Authors:  Jaume Alijotas-Reig; Enrique Esteve-Valverde; Ariadna Anunciación-Llunell; Joana Marques-Soares; Josep Pardos-Gea; Francesc Miró-Mur
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.